R&D News | pharmaphorum

News

Birth control pills on calendar (add vignette tone)

Pfizer/Myovant take relugolix contraceptive combination pill...

Pfizer and Myovant have begun a late-stage trial of their potential uterine fibroid drug relugolix, as part of a contraceptive combination tablet.

News

Romark eyes FDA okay for COVID antiviral despite mixed trial...

A phase 3 trial of Romark's antiviral drug NT-300 has missed the main objective in a phase 3 trial in mild to moderate COVID-19 patients, but could still have a shot at emergency use author

News

Akari begins late-stage trial of nomacopan for Bullous Pemph...

Akari Therapeutics is to begin a late-stage trial of nomacopan, its potential therapy for Bullous Pemphigoid, the rare autoimmune skin disorder.

News

Race for hepatitis B drug intensifies as Antios raises $96m ...

Antios has raised $96 million in Series B financing to support the ongoing phase 2 development of its hepatitis B drug candidate, ATI-2173.

News

Sanofi licences in potential oral IL-17 drug from UK's C4X D...

Sanofi has licensed a potential inflammatory diseases drug from Manchester University spin-off C4X Discovery Holdings in a deal worth up to €414 million ($492 million).

News